SEC Form 4 · accession 0001179110-16-019324
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Ann Cloyd
Director
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.21 | Feb 11, 2016 | A | 25,000 | A | — | Feb 10, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option was granted on February 11, 2016. This option vests in three equal annual installments over a three-year period from the date of grant.